Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration

Area of Science:

• Oncology
• Cell Biology
• Immunology

Background:

• Tumor metastasis is a major cause of cancer mortality, driven by tumor cell invasion.
• Autocrine motility factor (AMF) and insulin-like growth factors (IGFs) are known to induce tumor cell migration.
• Granulocyte-macrophase colony-stimulating factor (GM-CSF) primes neutrophils for chemotaxis.

Purpose of the Study:

• To investigate the effect of GM-CSF on tumor cell migration.
• To determine the dose-dependency and signaling pathways involved in GM-CSF-induced tumor cell chemotaxis.
• To assess the interaction of GM-CSF with other known tumor cell attractants.

Main Methods:

• Chemotaxis assays were performed on A2058 human melanoma cells using varying concentrations of GM-CSF.
• The effect of GM-CSF on cell migration was evaluated in combination with IGF-I and AMF.
• Signal pathway inhibitors, pertussis toxin (PT) and amiloride, were used to assess pathway sensitivity.
• Northern-blot analysis was conducted to detect GM-CSF receptor expression.

Main Results:

• GM-CSF stimulated melanoma cell migration in a dose-dependent manner, with an ED50 of approximately 60 pM.
• The migratory response to GM-CSF was additive to the effects of IGF-I and AMF.
• Pre-treatment with pertussis toxin or amiloride inhibited GM-CSF-induced chemotaxis by 50%.
• A2058 melanoma cells express GM-CSF receptor mRNA transcripts.

Conclusions:

• GM-CSF is a potent chemoattractant for melanoma cells.
• GM-CSF mediates its effects through pertussis toxin- and amiloride-sensitive signaling pathways.
• Melanoma cell migration is versatile and can be stimulated by multiple cytokines, including GM-CSF.